Ceritinib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-15656-5MG | 5 mg | 83,00 | Add | |
| HY-15656-1ML | 10mM/1mL | 98,00 | Add | |
| HY-15656-10MG | 10 mg | 111,00 | Add | |
| HY-15656-50MG | 50 mg | 153,00 | Add | |
| HY-15656-100MG | 100 mg | 222,00 | Add | |
| HY-15656-200MG | 200 mg | 348,00 | Add | |
| HY-15656-500MG | 500 mg | 641,00 | Add | |
| HY-15656-1G | 1 g | 1'059,00 | Add | |
| HY-15656-2G | 2 g | 1'686,00 | Add | |
| HY-15656-5G | 5 g | 3'357,00 | Add | |
| HY-15656-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib (LDK378) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib (LDK378) shows great antitumor potency[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Endocrinology, Protein Tyrosine Kinase/RTK |
| Format | Solubility: DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: Launched |
| Purity | 99.98% |
| Molecular Formula | C28H36ClN5O3S |
| Molecular Weight | 558.14 |
| CAS-Number | 1032900-25-6 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
